MRI-guided Transurethral UltraSound AblationWe perform MRI-guided Transurethral UltraSound Ablation (TULSA) in the prostate.
AimsWe perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. We can either treat the whole prostate or only a specific area of the prostate. The ablation device is inserted in the patient’s urethra. During ablation high-intensity ultrasound waves will destroy the prostate tissue. The ablation process is continuously monitored by real-time MR temperature mapping. A special balloon is inserted in the rectum to cool the rectal wall and to prevent it from heating.
Research within MITeCThe TULSA treatment is performed at the MITeC facility, under real-time MRI guidance. So, during the treatment, the patient is in the MR-scanner.
MITeC Connected operating rooms, for advancing innovation in patient care
MITeC offers unique consulting services and expertise to incorporate newly developed medical technology innovations and accelerate their success rate.read more